newsfilter
← Latest News
Business Wire·

Kardigan Announces Pricing of Upsized Initial Public Offering

Kardigan™, Inc. (NASDAQ:KARD) ("Kardigan"), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist,